Literature DB >> 25465197

Differences in the clinical features of two types of Vogt-Koyanagi-Harada disease: serous retinal detachment and optic disc swelling.

Yoko Okunuki1, Kinya Tsubota, Takeshi Kezuka, Hiroshi Goto.   

Abstract

PURPOSE: To elucidate the clinical differences between serous retinal detachment (RD)-type and optic disc (OD) swelling-type Vogt-Koyanagi-Harada (VKH) disease.
METHODS: We performed a retrospective review of 96 patients with new-onset, active VKH disease. Patients were classified into serous RD-type or OD swelling-type VKH disease groups by means of optical coherence tomography and fluorescein angiography, and the differences between the 2 groups were analyzed.
RESULTS: Eighty-two patients were classified as having RD-type VKH disease (34 men and 48 women, aged 40.5 ± 12.6 years) and 14 patients as having OD swelling-type VKH disease (1 man and 13 women, aged 54.6 ± 11.6 years). Patients with the OD swelling type had older onset (P < 0.001) and were more proportionately female (P = 0.02) than those with the RD type. OD swelling-type VKH disease had a longer interval between disease onset and treatment initiation (22.4 ± 14.0 days vs 12.6 ± 14.7 days; P = 0.02) and a higher frequency of chronic disease (64.3 vs 30.5 %; P = 0.03) than did serous RD-type VKH disease. In the OD swelling type, patients with pretreatment visual acuity (VA) lower than 20/20 developed chronic disease more frequently than did those with VA of 20/20 or better (P = 0.02).
CONCLUSIONS: Patients with OD swelling-type VKH disease are more likely to be female, have older onset, and develop chronic disease than patients with RD-type VKH disease. In OD swelling-type VKH disease, worse VA before treatment is associated with the development of chronic disease.

Entities:  

Mesh:

Year:  2014        PMID: 25465197     DOI: 10.1007/s10384-014-0367-8

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  16 in total

1.  Optic disc swelling in Vogt-Koyanagi-Harada disease.

Authors:  Kumiko Nakao; Noriko Abematsu; Yuka Mizushima; Taiji Sakamoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

2.  Effect of aging on foveolar choroidal circulation.

Authors:  J E Grunwald; S M Hariprasad; J DuPont
Journal:  Arch Ophthalmol       Date:  1998-02

3.  Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients.

Authors:  Masaru Miyanaga; Tatsushi Kawaguchi; Kazunori Miyata; Shintaro Horie; Manabu Mochizuki; Carl P Herbort
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

4.  Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

Authors:  R W Read; A Rechodouni; N Butani; R Johnston; L D LaBree; R E Smith; N A Rao
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

5.  Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.

Authors:  R W Read; G N Holland; N A Rao; K F Tabbara; S Ohno; L Arellanes-Garcia; P Pivetti-Pezzi; H H Tessler; M Usui
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

6.  Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome.

Authors:  P E Rubsamen; J D Gass
Journal:  Arch Ophthalmol       Date:  1991-05

7.  Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.

Authors:  Soon-Phaik Chee; Aliza Jap; Kristine Bacsal
Journal:  Am J Ophthalmol       Date:  2008-10-02       Impact factor: 5.258

8.  Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease.

Authors:  Shigeki Hirose; Wataru Saito; Kazuhiko Yoshida; Michiyuki Saito; Zhenyu Dong; Kenichi Namba; Hisao Satoh; Shigeaki Ohno
Journal:  Acta Ophthalmol       Date:  2008-11-12       Impact factor: 3.761

9.  Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease.

Authors:  Narsing A Rao; Amod Gupta; Laurie Dustin; Soon Phaik Chee; Annabelle A Okada; Moncef Khairallah; Bahram Bodaghi; Phuc Lehoang; Massimo Accorinti; Manabu Mochizuki; Tisha Prabriputaloong; Russell W Read
Journal:  Ophthalmology       Date:  2009-12-24       Impact factor: 12.079

10.  Vogt-Koyanagi-Harada disease in elderly Japanese patients.

Authors:  Chihiro Kiyomoto; Masamoto Imaizumi; Kenichi Kimoto; Hiromi Abe; Satoko Nakano; Kazuo Nakatsuka
Journal:  Int Ophthalmol       Date:  2007-04-14       Impact factor: 2.029

View more
  7 in total

1.  Vogt-Koyanagi-Harada syndrome presenting with bilateral optic disc swelling and leptomeningeal enhancement.

Authors:  Thanh-Thao Adriana Le; Sumu Simon; Jagjit Gilhotra; Pravin Hissaria
Journal:  BMJ Case Rep       Date:  2019-05-21

2.  De novo Vogt-Koyanagi-Harada disease after vaccination for COVID-19, successfully treated with systemic steroid therapy and monitored with laser speckle flowgraphy.

Authors:  Chiaki Yamaguchi; Hiroshi Kunikata; Kazuki Hashimoto; Masaaki Yoshida; Takahiro Ninomiya; Takehiro Hariya; Toshiaki Abe; Toru Nakazawa
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-11

Review 3.  Vogt-Koyanagi-Harada syndrome - current perspectives.

Authors:  Abeir Baltmr; Sue Lightman; Oren Tomkins-Netzer
Journal:  Clin Ophthalmol       Date:  2016-11-24

4.  "Revised diagnostic criteria" for Vogt-Koyanagi-Harada disease fail to improve disease management.

Authors:  Alireza Hedayatfar; Sana Khochtali; Moncef Khairallah; Masaru Takeuchi; Ahmed Abu El Asrar; Carl P Herbort
Journal:  J Curr Ophthalmol       Date:  2018-12-13

Review 5.  Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review.

Authors:  Cristhian A Urzua; Carl P Herbort; Masaru Takeuchi; Ariel Schlaen; Luz E Concha-Del-Rio; Yoshihiko Usui; Loreto Cuitino; Ioannis Papasavvas
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-05-12

6.  Clinical Comparative Study of Different Fundus Imaging Methods in the Acute Phase of Vogt-Koyanagi-Harada Disease.

Authors:  Hongyun Wu; Liqun Hu; Wei Tang; Guishang Chen; Jinrong Liu; Shaojun Li; Zhe Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-10       Impact factor: 2.650

7.  Morphologic Characteristics of Choroid in the Major Choroidal Thickening Diseases, Studied by Optical Coherence Tomography.

Authors:  Hoyoung Lee; Kunho Bae; Se Woong Kang; Se Joon Woo; Na-Kyung Ryoo; Sang Jin Kim; Gyule Han
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.